Adaptimmune Therapeutics plc ADAP

Quarterly report 2025-Q2
added 08-13-2025

Adaptimmune Therapeutics plc DIO Ratio 2011-2026 | ADAP

Quarterly DIO Ratio Adaptimmune Therapeutics plc

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
423	990	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
990	423	706

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Aptorum Group Limited APM	4.89	$ 0.83	2.17 %	$ 4.53 M	China
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Akebia Therapeutics AKBA	91.7	$ 1.49	7.19 %	$ 279 M	USA
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Arena Pharmaceuticals ARNA	160	-	-6.81 %	$ 3.04 B	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Amneal Pharmaceuticals AMRX	123	$ 14.49	-0.24 %	$ 4.48 B	USA
	Aytu BioScience AYTU	209	$ 2.35	-1.81 %	$ 14.8 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain